COVID‐19 and thalassemia beta major in splenectomized patient: Clinical case progression and literature review
<p dir="ltr">Although the possibility of asymptomatic course for COVID-19 infection in splenectomized thalassemia beta major patients is present, screening them for COVID-19 is important as the progression is still not clear.</p><h2>Other Information</h2><p dir=&...
محفوظ في:
| المؤلف الرئيسي: | |
|---|---|
| مؤلفون آخرون: | , , |
| منشور في: |
2020
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
| _version_ | 1864513566119297024 |
|---|---|
| author | Lina Okar (14777164) |
| author2 | Mohammad Ali (73095) Jabeed Parengal (12535533) Mohamed A. Yassin (8361183) |
| author2_role | author author author |
| author_facet | Lina Okar (14777164) Mohammad Ali (73095) Jabeed Parengal (12535533) Mohamed A. Yassin (8361183) |
| author_role | author |
| dc.creator.none.fl_str_mv | Lina Okar (14777164) Mohammad Ali (73095) Jabeed Parengal (12535533) Mohamed A. Yassin (8361183) |
| dc.date.none.fl_str_mv | 2020-09-12T21:00:00Z |
| dc.identifier.none.fl_str_mv | 10.1002/ccr3.3345 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/journal_contribution/COVID_19_and_thalassemia_beta_major_in_splenectomized_patient_Clinical_case_progression_and_literature_review/22257553 |
| dc.rights.none.fl_str_mv | CC BY 4.0 info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Biomedical and clinical sciences Cardiovascular medicine and haematology Immunology Health sciences Public health COVID-19 Thalassemia beta major Splenectomy Immune response Asymptomatic COVID-19 |
| dc.title.none.fl_str_mv | COVID‐19 and thalassemia beta major in splenectomized patient: Clinical case progression and literature review |
| dc.type.none.fl_str_mv | Text Journal contribution info:eu-repo/semantics/publishedVersion text contribution to journal |
| description | <p dir="ltr">Although the possibility of asymptomatic course for COVID-19 infection in splenectomized thalassemia beta major patients is present, screening them for COVID-19 is important as the progression is still not clear.</p><h2>Other Information</h2><p dir="ltr">Published in: Clinical Case Reports<br>License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="http://dx.doi.org/10.1002/ccr3.3345" target="_blank">http://dx.doi.org/10.1002/ccr3.3345</a></p> |
| eu_rights_str_mv | openAccess |
| id | Manara2_2e908c637d805524c7f4e379ada05acd |
| identifier_str_mv | 10.1002/ccr3.3345 |
| network_acronym_str | Manara2 |
| network_name_str | Manara2 |
| oai_identifier_str | oai:figshare.com:article/22257553 |
| publishDate | 2020 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY 4.0 |
| spelling | COVID‐19 and thalassemia beta major in splenectomized patient: Clinical case progression and literature reviewLina Okar (14777164)Mohammad Ali (73095)Jabeed Parengal (12535533)Mohamed A. Yassin (8361183)Biomedical and clinical sciencesCardiovascular medicine and haematologyImmunologyHealth sciencesPublic healthCOVID-19Thalassemia beta majorSplenectomyImmune responseAsymptomatic COVID-19<p dir="ltr">Although the possibility of asymptomatic course for COVID-19 infection in splenectomized thalassemia beta major patients is present, screening them for COVID-19 is important as the progression is still not clear.</p><h2>Other Information</h2><p dir="ltr">Published in: Clinical Case Reports<br>License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="http://dx.doi.org/10.1002/ccr3.3345" target="_blank">http://dx.doi.org/10.1002/ccr3.3345</a></p>2020-09-12T21:00:00ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.1002/ccr3.3345https://figshare.com/articles/journal_contribution/COVID_19_and_thalassemia_beta_major_in_splenectomized_patient_Clinical_case_progression_and_literature_review/22257553CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/222575532020-09-12T21:00:00Z |
| spellingShingle | COVID‐19 and thalassemia beta major in splenectomized patient: Clinical case progression and literature review Lina Okar (14777164) Biomedical and clinical sciences Cardiovascular medicine and haematology Immunology Health sciences Public health COVID-19 Thalassemia beta major Splenectomy Immune response Asymptomatic COVID-19 |
| status_str | publishedVersion |
| title | COVID‐19 and thalassemia beta major in splenectomized patient: Clinical case progression and literature review |
| title_full | COVID‐19 and thalassemia beta major in splenectomized patient: Clinical case progression and literature review |
| title_fullStr | COVID‐19 and thalassemia beta major in splenectomized patient: Clinical case progression and literature review |
| title_full_unstemmed | COVID‐19 and thalassemia beta major in splenectomized patient: Clinical case progression and literature review |
| title_short | COVID‐19 and thalassemia beta major in splenectomized patient: Clinical case progression and literature review |
| title_sort | COVID‐19 and thalassemia beta major in splenectomized patient: Clinical case progression and literature review |
| topic | Biomedical and clinical sciences Cardiovascular medicine and haematology Immunology Health sciences Public health COVID-19 Thalassemia beta major Splenectomy Immune response Asymptomatic COVID-19 |